Tapewire

Nasdaq · USD

BMRN

BIOMARIN PHARMACEUTICAL INC

Export transactions ↓
Tapewire entity
2404
SEC CIK
0001048477
Parsed reports
685

Last 12 months

Inside the activity.

0 purchase rows · 5 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202602
Mar 202601
Apr 202600
May 202601
Jun 202600
Jul 202600
Aug 202600
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 13, 2018 Filed Sep 17, 2018 23:22 UTC SaleCommon Stock 200 $99.25 $19,850.00
Disclosure

SEC source: 0001567619-18-002765 · doc1.xml · nonDerivative · entry 4

MEIER RICHARD A · CIK 0001227305 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,610

Read SEC document
September 13, 2018 Filed Sep 17, 2018 23:22 UTC SaleCommon Stock 2,800 $99.24 $277,872.00
Disclosure

SEC source: 0001567619-18-002765 · doc1.xml · nonDerivative · entry 3

MEIER RICHARD A · CIK 0001227305 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,810

Read SEC document
September 13, 2018 Filed Sep 17, 2018 23:22 UTC Exercise / conversionCommon Stock 3,000 $21.51 $64,530.00
Disclosure

SEC source: 0001567619-18-002765 · doc1.xml · nonDerivative · entry 2

MEIER RICHARD A · CIK 0001227305 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,610

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 13, 2018 Filed Sep 17, 2018 23:22 UTC Exercise / conversionCommon Stock 12,000 $21.51 $258,120.00
Disclosure

SEC source: 0001567619-18-002765 · doc1.xml · nonDerivative · entry 1

MEIER RICHARD A · CIK 0001227305 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,610

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 13, 2018 Filed Sep 17, 2018 22:57 UTC
Davis George EricEVP, General Counsel
SaleCommon Stock 12,000 $99.57 $1,194,840.00
Disclosure

SEC source: 0001567619-18-002760 · doc1.xml · nonDerivative · entry 1

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,950

F1 · kind: The reporting person contributed shares of common stock of BioMarin Pharmaceutical Inc. (the "Common Stock") to an exchange fund in exchange for shares of the exchange fund. The Common Stock was valued at $99.57 per share for the purpose of determining the number of shares of the exchange fund issuable to the reporting person.

F1 · price: The reporting person contributed shares of common stock of BioMarin Pharmaceutical Inc. (the "Common Stock") to an exchange fund in exchange for shares of the exchange fund. The Common Stock was valued at $99.57 per share for the purpose of determining the number of shares of the exchange fund issuable to the reporting person.

Read SEC document
September 05, 2018 Filed Sep 7, 2018 18:00 UTC SaleCommon Stock 1,000 $96.94 $96,935.00
Disclosure

SEC source: 0001567619-18-002256 · doc1.xml · nonDerivative · entry 1

HERON ELAINE J · CIK 0001235471 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,685

Read SEC document
September 04, 2018 Filed Sep 6, 2018 21:41 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 1,500 $0.00 Strike: $17.86 $0.00
Disclosure

SEC source: 0001567619-18-002210 · doc1.xml · derivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,000

Underlying: Common Stock · 1,500 shares

Expires 2018-12-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 21, 2018.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
September 04, 2018 Filed Sep 6, 2018 21:41 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 1,500 $98.16 $147,240.00
Disclosure

SEC source: 0001567619-18-002210 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 285,290

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 21, 2018.

Read SEC document
September 04, 2018 Filed Sep 6, 2018 21:41 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 1,500 $17.86 $26,790.00
Disclosure

SEC source: 0001567619-18-002210 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 286,790

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 21, 2018.

Read SEC document
August 28, 2018 Filed Aug 30, 2018 17:55 UTC
LEWIS ALANDirector
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 7,500 $0.00 Strike: $14.39 $0.00
Disclosure

SEC source: 0001567619-18-001925 · doc1.xml · derivative · entry 4

LEWIS ALAN · CIK 0001207604 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,500 shares

Expires 2019-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
August 28, 2018 Filed Aug 30, 2018 17:55 UTC
LEWIS ALANDirector
SaleCommon Stock 200 $99.12 $19,824.00
Disclosure

SEC source: 0001567619-18-001925 · doc1.xml · nonDerivative · entry 3

LEWIS ALAN · CIK 0001207604 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,160

Read SEC document
August 28, 2018 Filed Aug 30, 2018 17:55 UTC
LEWIS ALANDirector
SaleCommon Stock 7,300 $99.11 $723,503.00
Disclosure

SEC source: 0001567619-18-001925 · doc1.xml · nonDerivative · entry 2

LEWIS ALAN · CIK 0001207604 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,360

Read SEC document
August 28, 2018 Filed Aug 30, 2018 17:55 UTC
LEWIS ALANDirector
Exercise / conversionCommon Stock 7,500 $14.39 $107,925.00
Disclosure

SEC source: 0001567619-18-001925 · doc1.xml · nonDerivative · entry 1

LEWIS ALAN · CIK 0001207604 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,660

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 27, 2018 Filed Aug 28, 2018 21:54 UTC
FUCHS HENRY JPresident, Worldwide R&D
SaleCommon Stock 12,500 $100.00 $1,250,000.00
Disclosure

SEC source: 0001567619-18-001851 · doc1.xml · nonDerivative · entry 2

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,167

Read SEC document
August 27, 2018 Filed Aug 29, 2018 19:51 UTC Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 13,000 $0.00 Strike: $14.39 $0.00
Disclosure

SEC source: 0001567619-18-001878 · doc1.xml · derivative · entry 5

MEIER RICHARD A · CIK 0001227305 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,000 shares

Expires 2019-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
August 27, 2018 Filed Aug 29, 2018 19:51 UTC Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 2,000 $0.00 Strike: $14.39 $0.00
Disclosure

SEC source: 0001567619-18-001878 · doc1.xml · derivative · entry 4

MEIER RICHARD A · CIK 0001227305 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,000

Underlying: Common Stock · 2,000 shares

Expires 2019-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
August 27, 2018 Filed Aug 29, 2018 19:51 UTC SaleCommon Stock 2,000 $100.12 $200,235.40
Disclosure

SEC source: 0001567619-18-001878 · doc1.xml · nonDerivative · entry 3

MEIER RICHARD A · CIK 0001227305 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,610

F1 · price: The price in column 4 is the weighted average price. The price actually received ranged from $100.112 to $100.130. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

Read SEC document
August 27, 2018 Filed Aug 29, 2018 19:51 UTC Exercise / conversionCommon Stock 2,000 $14.39 $28,780.00
Disclosure

SEC source: 0001567619-18-001878 · doc1.xml · nonDerivative · entry 2

MEIER RICHARD A · CIK 0001227305 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,610

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 27, 2018 Filed Aug 29, 2018 19:51 UTC Exercise / conversionCommon Stock 13,000 $14.39 $187,070.00
Disclosure

SEC source: 0001567619-18-001878 · doc1.xml · nonDerivative · entry 1

MEIER RICHARD A · CIK 0001227305 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,610

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 24, 2018 Filed Aug 28, 2018 21:54 UTC
FUCHS HENRY JPresident, Worldwide R&D
SaleCommon Stock 12,500 $99.00 $1,237,500.00
Disclosure

SEC source: 0001567619-18-001851 · doc1.xml · nonDerivative · entry 1

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 142,667

Read SEC document
August 21, 2018 Filed Aug 22, 2018 23:06 UTC
LEWIS ALANDirector
SaleCommon Stock 4,200 $100.09 $420,365.40
Disclosure

SEC source: 0001567619-18-001677 · doc1.xml · nonDerivative · entry 1

LEWIS ALAN · CIK 0001207604 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,160

F1 · price: The price in column 4 is the weighted average price. The price actually received ranged from $100.07 to $100.11. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

Read SEC document
August 07, 2018 Filed Aug 9, 2018 20:58 UTC
BAFFI ROBERTEVP, Technical Operations
SaleCommon Stock 5,173 $105.00 $543,165.00
Disclosure

SEC source: 0001567619-18-000257 · doc1.xml · nonDerivative · entry 2

BAFFI ROBERT · CIK 0001274826 · EVP, Technical Operations

10b5-1 filing: Not disclosed

Ownership: Indirect · Shares held by Baffi Family Trust

Disclosed balance after: 71,882

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 12, 2017.

Read SEC document
August 07, 2018 Filed Aug 9, 2018 20:27 UTC
Mueller BrianSVP, Corporate Controller
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 782 $0.00 Strike: $28.23 $0.00
Disclosure

SEC source: 0001567619-18-000239 · doc1.xml · derivative · entry 5

Mueller Brian · CIK 0001514980 · SVP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,709

Underlying: Common Stock · 782 shares

Expires 2021-05-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on March 9, 2018.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
August 07, 2018 Filed Aug 9, 2018 20:27 UTC
Mueller BrianSVP, Corporate Controller
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 1,718 $0.00 Strike: $28.23 $0.00
Disclosure

SEC source: 0001567619-18-000239 · doc1.xml · derivative · entry 4

Mueller Brian · CIK 0001514980 · SVP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,718 shares

Expires 2021-05-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on March 9, 2018.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
August 07, 2018 Filed Aug 9, 2018 20:27 UTC
Mueller BrianSVP, Corporate Controller
SaleCommon Stock 2,500 $104.50 $261,250.00
Disclosure

SEC source: 0001567619-18-000239 · doc1.xml · nonDerivative · entry 3

Mueller Brian · CIK 0001514980 · SVP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,375

F1 · date: Trade made pursuant to a 10b5-1 plan executed on March 9, 2018.

Read SEC document
August 07, 2018 Filed Aug 9, 2018 20:27 UTC
Mueller BrianSVP, Corporate Controller
Exercise / conversionCommon Stock 782 $28.23 $22,075.86
Disclosure

SEC source: 0001567619-18-000239 · doc1.xml · nonDerivative · entry 2

Mueller Brian · CIK 0001514980 · SVP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,875

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on March 9, 2018.

Read SEC document
August 07, 2018 Filed Aug 9, 2018 20:27 UTC
Mueller BrianSVP, Corporate Controller
Exercise / conversionCommon Stock 1,718 $28.23 $48,499.14
Disclosure

SEC source: 0001567619-18-000239 · doc1.xml · nonDerivative · entry 1

Mueller Brian · CIK 0001514980 · SVP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,093

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on March 9, 2018.

Read SEC document
July 23, 2018 Filed Jul 25, 2018 23:47 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 1,500 $0.00 Strike: $17.86 $0.00
Disclosure

SEC source: 0001140361-18-033548 · doc1.xml · derivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,500

Underlying: Common Stock · 1,500 shares

Expires 2018-12-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 21, 2018.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
July 23, 2018 Filed Jul 25, 2018 23:47 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 1,500 $101.69 $152,535.00
Disclosure

SEC source: 0001140361-18-033548 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 285,290

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 21, 2018.

Read SEC document
July 23, 2018 Filed Jul 25, 2018 23:47 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 1,500 $17.86 $26,790.00
Disclosure

SEC source: 0001140361-18-033548 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 286,790

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 21, 2018.

Read SEC document
June 27, 2018 Filed Jun 29, 2018 21:59 UTC Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 2,150 $0.00 Strike: $14.39 $0.00
Disclosure

SEC source: 0001140361-18-030752 · doc1.xml · derivative · entry 3

LAWLIS V BRYAN · CIK 0001247681 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,450

Underlying: Common Stock · 2,150 shares

Expires 2019-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on June 12, 2018.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
June 27, 2018 Filed Jun 29, 2018 21:59 UTC SaleCommon Stock 2,150 $93.52 $201,068.00
Disclosure

SEC source: 0001140361-18-030752 · doc1.xml · nonDerivative · entry 2

LAWLIS V BRYAN · CIK 0001247681 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,160

F1 · date: Trade made pursuant to a 10b5-1 plan executed on June 12, 2018.

Read SEC document
June 27, 2018 Filed Jun 29, 2018 21:59 UTC Exercise / conversionCommon Stock 2,150 $14.39 $30,938.50
Disclosure

SEC source: 0001140361-18-030752 · doc1.xml · nonDerivative · entry 1

LAWLIS V BRYAN · CIK 0001247681 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,310

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on June 12, 2018.

Read SEC document
June 22, 2018 Filed Jun 27, 2018 00:31 UTC
SPIEGELMAN DANIEL KEVP, Chief Financial Officer
SaleCommon Stock 472 $99.01 $46,732.72
Disclosure

SEC source: 0001140361-18-030011 · doc1.xml · nonDerivative · entry 2

SPIEGELMAN DANIEL K · CIK 0001238403 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,070

F1 · date: Trade made pursuant to a 10b5-1 plan executed on August 15, 2017.

Read SEC document
June 22, 2018 Filed Jun 27, 2018 00:31 UTC
SPIEGELMAN DANIEL KEVP, Chief Financial Officer
SaleCommon Stock 9,528 $99.00 $943,272.00
Disclosure

SEC source: 0001140361-18-030011 · doc1.xml · nonDerivative · entry 1

SPIEGELMAN DANIEL K · CIK 0001238403 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,542

F1 · date: Trade made pursuant to a 10b5-1 plan executed on August 15, 2017.

Read SEC document
June 22, 2018 Filed Jun 27, 2018 00:23 UTC
BAFFI ROBERTEVP, Technical Operations
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 6,949 $0.00 Strike: $14.39 $0.00
Disclosure

SEC source: 0001140361-18-030008 · doc1.xml · derivative · entry 5

BAFFI ROBERT · CIK 0001274826 · EVP, Technical Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,949 shares

Expires 2019-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on March 6, 2018.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
June 22, 2018 Filed Jun 27, 2018 00:23 UTC
BAFFI ROBERTEVP, Technical Operations
SaleCommon Stock 328 $99.01 $32,475.28
Disclosure

SEC source: 0001140361-18-030008 · doc1.xml · nonDerivative · entry 3

BAFFI ROBERT · CIK 0001274826 · EVP, Technical Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,276

F1 · date: Trade made pursuant to a 10b5-1 plan executed on March 6, 2018.

Read SEC document
June 22, 2018 Filed Jun 27, 2018 00:23 UTC
BAFFI ROBERTEVP, Technical Operations
SaleCommon Stock 6,621 $99.00 $655,479.00
Disclosure

SEC source: 0001140361-18-030008 · doc1.xml · nonDerivative · entry 2

BAFFI ROBERT · CIK 0001274826 · EVP, Technical Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,604

F1 · date: Trade made pursuant to a 10b5-1 plan executed on March 6, 2018.

Read SEC document
June 22, 2018 Filed Jun 27, 2018 00:23 UTC
BAFFI ROBERTEVP, Technical Operations
Exercise / conversionCommon Stock 6,949 $14.39 $99,996.11
Disclosure

SEC source: 0001140361-18-030008 · doc1.xml · nonDerivative · entry 1

BAFFI ROBERT · CIK 0001274826 · EVP, Technical Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,225

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on March 6, 2018.

Read SEC document
June 22, 2018 Filed Jun 27, 2018 00:15 UTC
Mueller BrianSVP, Corporate Controller
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 2,491 $0.00 Strike: $28.23 $0.00
Disclosure

SEC source: 0001140361-18-030005 · doc1.xml · derivative · entry 4

Mueller Brian · CIK 0001514980 · SVP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,718

Underlying: Common Stock · 2,491 shares

Expires 2021-05-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on March 9, 2018.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
June 22, 2018 Filed Jun 27, 2018 00:15 UTC
Mueller BrianSVP, Corporate Controller
SaleCommon Stock 2,491 $99.50 $247,854.50
Disclosure

SEC source: 0001140361-18-030005 · doc1.xml · nonDerivative · entry 3

Mueller Brian · CIK 0001514980 · SVP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,375

F1 · date: Trade made pursuant to a 10b5-1 plan executed on March 9, 2018.

Read SEC document
June 22, 2018 Filed Jun 27, 2018 00:15 UTC
Mueller BrianSVP, Corporate Controller
Exercise / conversionCommon Stock 2,491 $28.23 $70,320.93
Disclosure

SEC source: 0001140361-18-030005 · doc1.xml · nonDerivative · entry 2

Mueller Brian · CIK 0001514980 · SVP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,866

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on March 9, 2018.

Read SEC document
June 22, 2018 Filed Jun 27, 2018 00:15 UTC
Mueller BrianSVP, Corporate Controller
SaleCommon Stock 654 $99.50 $65,073.00
Disclosure

SEC source: 0001140361-18-030005 · doc1.xml · nonDerivative · entry 1

Mueller Brian · CIK 0001514980 · SVP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,375

F1 · date: Trade made pursuant to a 10b5-1 plan executed on March 9, 2018.

Read SEC document
June 15, 2018 Filed Jun 19, 2018 00:30 UTC
Mueller BrianSVP, Corporate Controller
SaleCommon Stock 2,021 $94.50 $190,984.50
Disclosure

SEC source: 0001140361-18-029042 · doc1.xml · nonDerivative · entry 1

Mueller Brian · CIK 0001514980 · SVP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,029

F1 · date: Trade made pursuant to a 10b5-1 plan executed on March 9, 2018.

Read SEC document
June 14, 2018 Filed Jun 19, 2018 00:11 UTC
FUCHS HENRY JPresident, Worldwide R&D
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 20,681 $0.00 Strike: $37.46 $0.00
Disclosure

SEC source: 0001140361-18-029033 · doc1.xml · derivative · entry 15

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,681 shares

Expires 2022-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 30, 2018.

F3 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
June 14, 2018 Filed Jun 19, 2018 00:11 UTC
FUCHS HENRY JPresident, Worldwide R&D
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 1,875 $0.00 Strike: $26.49 $0.00
Disclosure

SEC source: 0001140361-18-029033 · doc1.xml · derivative · entry 14

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,875 shares

Expires 2021-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 30, 2018.

F3 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
June 14, 2018 Filed Jun 19, 2018 00:11 UTC
FUCHS HENRY JPresident, Worldwide R&D
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 2,669 $0.00 Strike: $37.46 $0.00
Disclosure

SEC source: 0001140361-18-029033 · doc1.xml · derivative · entry 13

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,669 shares

Expires 2022-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 30, 2018.

F3 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
June 14, 2018 Filed Jun 19, 2018 00:11 UTC
FUCHS HENRY JPresident, Worldwide R&D
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 3,775 $0.00 Strike: $26.49 $0.00
Disclosure

SEC source: 0001140361-18-029033 · doc1.xml · derivative · entry 12

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,775 shares

Expires 2021-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 30, 2018.

F3 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
June 14, 2018 Filed Jun 19, 2018 00:11 UTC
FUCHS HENRY JPresident, Worldwide R&D
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 2,000 $0.00 Strike: $21.51 $0.00
Disclosure

SEC source: 0001140361-18-029033 · doc1.xml · derivative · entry 11

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,000 shares

Expires 2020-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 30, 2018.

F3 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
June 14, 2018 Filed Jun 19, 2018 00:11 UTC
FUCHS HENRY JPresident, Worldwide R&D
SaleCommon Stock 20,681 $90.00 $1,861,374.79
Disclosure

SEC source: 0001140361-18-029033 · doc1.xml · nonDerivative · entry 10

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 155,167

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 30, 2018.

F2 · price: The price in column 4 is the weighted average price. The price actually received ranged from $90.00 to $90.07. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.